A Food and Drug Administration advisory panel on Monday endorsed the experimental Alzheimer's drug donanemab that studies showed slowed early stages of the fatal mind-robbing disease. The ...

WASHINGTON (AP) — A closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment's expected approval for people with mild ...

In the first three months of 2024, there were 323 active drug shortages, the highest number since 2001, according to research ...

A panel of expert advisers to the U.S. Food and Drug Administration voted unanimously on Monday to back Eli Lilly’s ...

Food and beverage recalls administered by the U.S. Food and Drug Administration (FDA) occur regularly, although some products ...

As the F.D.A. considers a new Alzheimer’s medication, we asked experts how the rollout of a similar drug has gone.

Soon there could be nutrition labels on the front of food packages at the grocery store — not just on the back or side.

Mesoblast has had a welcome turnaround in its fortunes on the regulatory front this year and the company looks forward to ...

FDA advisers are set to review an Alzheimer's drug found to slow the disease's progress in patients in the early stages. The big questions are about how the drug should be marketed.

FDA clears GSK's RSV vaccine for adults ages 50-59 June 8 (UPI) -- The U.S. Food and Drug Administration on Friday approved ...

The company might finally get an answer—or the first clues to an answer–this week. On Monday, a panel of advisers to the U.S.

A panel of independent advisors to the FDA recommended Eli Lilly's Alzheimer's drug donanemab, paving the way for the ...